• Home
  • NEW DAY MEDICINE
  • 5 (79) 2025
  • 184 -5 (79) 2025 - Abdullaeva M.N., Jabborov U.U. - INTRAUTERINE CYTOKINE PARAMETERS OF THE FETUS WITH HEMOLYTIC DISEASE DEPENDING ON THE GESTATION PERIOD

184 -5 (79) 2025 - Abdullaeva M.N., Jabborov U.U. - INTRAUTERINE CYTOKINE PARAMETERS OF THE FETUS WITH HEMOLYTIC DISEASE DEPENDING ON THE GESTATION PERIOD

INTRAUTERINE CYTOKINE PARAMETERS OF THE FETUS WITH HEMOLYTIC DISEASE DEPENDING ON THE GESTATION PERIOD

Abdullaeva M.N. - Republican Perinatal Center, Uzbekistan

Jabborov U.U. - Central Asian Medical University

Resume

This study assessed the cytokine profile of fetuses with hemolytic disease depending on gestational age in Rh-immunized pregnancies. Comparison showed higher levels of IL-18, IL-6, and TNF-α in the third trimester. IL-18 increase correlated with intensified inflammatory responses

Keywords: Rh immunization, fetal hemolytic disease, cytokines, IL-18, IL-6, TNF-α, IL-4

First page

911

Last page

914

For citation:Abdullaeva M.N., Jabborov U.U. - INTRAUTERINE CYTOKINE PARAMETERS OF THE FETUS WITH HEMOLYTIC DISEASE DEPENDING ON THE GESTATION PERIOD//New Day in Medicine 5(79)2025 911-914 https://newdayworldmedicine.com/en/new_day_medicine/5-79-2025

List of References

  1. Winter DP, Kaminski A, Tjoa ML, Oepkes D: Hemolytic disease of the fetus and newborn: systematic literature review of the antenatal landscape. BMC Pregnancy Childbirth. 2023, 23:12. 10.1186/s12884-022-05329-z
  2. Ghidini A: Fetal Blood Sampling. UpToDate. UpToDate, Waltham, MA; 2022.
  3. Moise Jr KJ: Intrauterine fetal transfusion of red cells. UpToDate. UpToDate, Waltham, MA; 2023.
  4. Zwiers C, Lindenburg IT, Klumper FJ, de Haas M, Oepkes D, Van Kamp IL: Complications of intrauterine intravascular blood transfusion: lessons learned after 1678 procedures. Ultrasound Obstet Gynecol. 2017, 50:180-6. 10.1002/uog.17319
  5. Mayer B, Hinkson L, Hillebrand W, Henrich W, Salama A: Efficacy of antenatal intravenous immunoglobulin treatment in pregnancies at high risk due to alloimmunization to red blood cells. Transfus Med Hemother. 2018, 45:429-36. 10.1159/000490154.
  6. K.J. Jr. Moise, P.S. Argoti, Management and prevention of red cell alloimmunization in pregnancy: a systematic review. Obstet Gynecol, 120 (2012), pp. 1132-1139
  7. Жабборов У.У., Расуль-Заде Ю.Г. Новый взгляд на проблему резус-иммунизации в Республике Узбекистан. Медицинские новости №4, 2020 стр.83-86 Минск.
  8. McAdams RM. Time to implement delayed cord clamping. Obstet Gynecol 2014; 123:549–52.
  9. Garabedian C, Rakza T, Drumez E, Poleszczuk M, Ghesquiere L, Wibaut B, et al. Benefits of delayed cord clamping in red blood cell alloimmunization. Pediatrics 2016;137: e20153236.
  10. Жабборов У.У., Расуль-Заде Ю.Г., Исмаилова А.А., Цитокиновый статус у плода с гемолитической болезнью при резус-иммунизации матери. Инфекция, иммунитет и фармакология №4, 2020 стр.65-70 Ташкент.

    file

    download